Frequency of HER-2 Positivity in Rectal Cancer and Prognosis

Lena‐Christin Conradi, Hanna Styczen, Thilo Sprenger, +13

The American Journal of Surgical Pathology

Surgical OncologyEndocrine-related CancerGastrointestinal OncologyMedicineHer-2 Amplification +11

Enrichment of CD133‐expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival

Thilo Sprenger, Lena‐Christin Conradi, Tim Beißbarth, +11

Cancer

Long-term prognostic impact of surgical complications in the German Rectal Cancer Trial CAO/ARO/AIO-94

Thilo Sprenger, Tim Beißbarth, Rolf Sauer, +9

British journal of surgery

Optimal Lymph Node Harvest in Rectal Cancer (UICC Stages II and III) after Preoperative 5-FU–based Radiochemotherapy. Acetone Compression is a New and Highly Efficient Method

Anastasia Gehoff, O. Basten, Thilo Sprenger, +14

The American Journal of Surgical Pathology

Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases

Kia Homayounfar, Annalen Bleckmann, H-J Helms, +6

British journal of surgery

Preoperative Chemoradiotherapy Does Not Necessarily Reduce Lymph Node Retrieval in Rectal Cancer Specimens—Results from a Prospective Evaluation with Extensive Pathological Work-up

Thilo Sprenger, Hilka Rothe, Kia Homayounfar, +4

Journal of Gastrointestinal Surgery

Failure of Downregulation of Survivin Following Neoadjuvant Radiochemotherapy in Rectal Cancer Is Associated with Distant Metastases and Shortened Survival

Thilo Sprenger, Franz Rödel, Tim Beißbarth, +9

Clinical Cancer Research

Lymph Node Metastases in Rectal Cancer After Preoperative Radiochemotherapy

Thilo Sprenger, Hilka Rothe, Heinz Becker, +9

The American Journal of Surgical Pathology

HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer

Hanna Styczen, Iris Nagelmeier, Tim Beißbarth, +12

Oncotarget

Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup

Thilo Sprenger, Hilka Rothe, Lena‐Christin Conradi, +11

Diseases of the Colon & Rectum